Employee Stock Purchase and Stock Incentive Plans (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Issuance Activity Under Employee Stock Purchase Plan

The following table summarizes the stock issuance activity under the ESPP for the three months ended March 31, 2023 (in thousands, except share data):

	March 31, 2023
Total purchase price paid by employees for shares sold	$	383
Number of shares sold	16,039

Summary of Status of Stock Options Exercised, Including Substantive Options and Information about Options Outstanding and Exercisable

A summary of the status of stock options exercised, including the substantive options discussed in Note 3, is as follows:

	Number of shares	Weighted Average Exercise Price
Outstanding at December 31, 2022	10,030	$	5.99
Granted	–	–
Exercised	(1,121)	5.95
Expired or cancelled	–	–
Outstanding at March 31, 2023	8,909	$	6.00

The following summarizes information about options outstanding and exercisable at January 1, 2023 and March 31, 2023:

	Options Outstanding and Exercisable
	Exercise Price		Total Outstanding	Weighted Average Remaining Life (Years)	Weighted Average Exercise Price		Total Exercisable
December 31, 2022	$	6.28	10,030	5.0	$	5.99	10,030
March 31, 2023	$	6.28	8,909	5.0	$	6.00	8,909

Summary of Activity of Restricted Shares Subject to Forfeiture

The following table summarizes the activity of restricted shares subject to forfeiture:

	Number of shares	Weighted Average Grant Price
Outstanding at January 1, 2023	1,837,309	14.33
Granted	59,437	24.83
Vested	(127,190)	13.19
Cancelled	(5,680)	18.73
Outstanding at March 31, 2023	1,763,876	14.77

Summary of Activity of Performance Stock Units Subject to Forfeiture

The following table summarizes the activity of performance stock units subject to forfeiture:

	Number of shares	Weighted Average Grant Price
Outstanding at January 1, 2023	447,429	12.95
Granted	245,710	22.94
Vested	–	–
Cancelled	–	–
Outstanding at March 31, 2023	693,139	16.49

Summary of Change in Liability to Common Shares Subject to Repurchase and Associated Non Cash Compensation Expense

The following table represents the change in the liability to common shares subject to repurchase and the associated non-cash compensation expense for the three months ended March 31, 2023 and the year ended December 31, 2022 (in thousands):

	March 31, 2023		December 31, 2022
Beginning Balance	$	–	$	7
Non-cash compensation from ratable vesting	$	–	–
Non-cash compensation from change in fair value of liability	$	–	–
Other stock activity, net	$	–	(7)
Reclassification upon modification	–		–
Ending balance	$	–	$	–

Summary of Future Expense of Unvested Awards

The future expense of the unvested awards for the remainder of 2023 and succeeding years is as follows (in thousands):

2023	$	11,437
2024	9,339
2025	4,286
2026	356
Thereafter	17
Total	$	25,435